Call us directly: +44 (0)7905 201857

Email us

Members log in

Aug 18

UKTI Export to Japan Trade Mission – Regenerative Medicine Mission 2015

Export to JapanIn Japan, a regulation reform will be implemented in November 2014 in the area of regenerative medicine.  Companies will be given conditional marketing approval after Phase II trials on the basis that products are proved to be safe and effective to use.  Detailed regulatory process and conditions are under discussion and to be announced in due course, and this will give an accelerated path to market entry not only in Japan but also globally.

The Science & Innovation Japan Team organised a “Symposium for Innovation in Regenerative Medicine” in January 2014, inviting regulators, scientists and companies from both the UK and Japan.  In order to deepen and extend the discussion to real commercialisation, UKTI and the Science & Innovation Team are planning to organise another symposium in January 2015 in cooperation with Takeda Science Foundation and CiRA Kyoto University (Centre for iPS Cell Research & Application). The eligible UK companies will be provided a product/technology showcasing opportunity at a speaking slot in the seminar programme.

The event is designated as the satellite workshop of the 18th Takeda Science Foundation Symposium on Biosciences, and this market visit and associated events are planned in the same week of Takeda Science Foundation’s symposium. You will also have an opportunity to attend this symposium (15- 17 January 2015) as a visitor and join a poster presentation.
The closing date for registration for the poster presentation is 30th September 2014, and for the symposium is 31st October 2014.  For futher details on the Takeda Science Foundation Symposium, please click here
For further information on the event and to register please click here